Dechra Pharma accepts cash bid
Veterinary drug company Dechra Pharmaceuticals has finally accepted the all-cash offer for the business of $44 billion, or £38.75 a share.
That offer was originally announced on 14 April but has only just been accepted by the Dechra board. It is from the Swedish investment firm EQT and is cash, valuing the veterinary group at £4.88bln.
Related articles
Live prices on most popular markets
- Equities
- Indices
- Forex
- Commodities
Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.